Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin Pretreatment in Liver Transplant Donors
NCT01860716Phase 3Unknown
- Sponsor
- Instituto Aragonés de Ciencias de la Salud
- Start
- May 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in ischemia-reperfusion injury (IRI), sponsored by Instituto Aragonés de Ciencias de la Salud. Status: unknown.
02
Drugs
melatonin
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT01860716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860716.